Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.59 | 0.03 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.092 | 0.03 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.03 |